{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:05:16Z","timestamp":1787061916530,"version":"build-2736575974"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA250214"],"award-info":[{"award-number":["CA250214"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microbiome"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Salivary agglutinin, also known as deleted in malignant brain tumors 1 (DMBT1), is an anti-microbial protein. DMBT1 is low in saliva from patients with oral squamous cell carcinoma (OSCC) and dramatically increases after treatment, with accompanying microbial changes. While this suggests an association between DMBT1 suppression and changes in the oral microbiota, causation has not been established. DMBT1 is also a tumor suppressor protein; its loss promotes OSCC progression, but its role in OSCC development is unknown. In this study, OSCC development was investigated in a murine carcinogen model that simulates human OSCC. Microbiota were standardized between\n                      <jats:italic>Dmbt1<\/jats:italic>\n                      knockout (\n                      <jats:italic>Dmbt1<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      ) and wild-type (\n                      <jats:italic>Dmbt1<\/jats:italic>\n                      <jats:sup>\n                        +\n                        <jats:italic>\/<\/jats:italic>\n                        +\n                      <\/jats:sup>\n                      ) mice via interbreeding and co-housing. Saliva was collected at baseline and at 4, 8, 12, 16, and 22\u00a0weeks post-carcinogen initiation (stopped at 16\u00a0weeks). Tongues were harvested at week 22 for histopathology, and the salivary microbiome was profiled by 16S rRNA sequencing. Microbial diversity metrics and conditional dependence networks assessed community structure, while longitudinal patterns were analyzed using a locally sparse varying coefficient mixed model and functional principal component analysis (fPCA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Despite microbiota standardization,\n                      <jats:italic>Dmbt1<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      and\n                      <jats:italic>Dmbt1<\/jats:italic>\n                      <jats:sup>\n                        +\n                        <jats:italic>\/<\/jats:italic>\n                        +\n                      <\/jats:sup>\n                      displayed differences in microbiome composition based on \u03b2-diversity metrics. At endpoint, carcinogen-treated\n                      <jats:italic>Dmbt1<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      showed higher OSCC prevalence and more aggressive invasion than\n                      <jats:italic>Dmbt1<\/jats:italic>\n                      <jats:sup>\n                        +\n                        <jats:italic>\/<\/jats:italic>\n                        +\n                      <\/jats:sup>\n                      . Several OTUs, including those from Lachnospiraceae,\n                      <jats:italic>Sphingomonas<\/jats:italic>\n                      , Carnobacteriaceae, and Candidatus Saccharibacteria families, demonstrated differential abundance patterns over time, either genotype-specific, diagnosis-specific, or both. Notably,\n                      <jats:italic>Sphingomonas<\/jats:italic>\n                      and Lachnospiraceae exhibited time-dependent abundance differences in mice that developed OSCC. fPCA identified taxa with abundance trajectories that were different between OSCC and precancer and genotype specific.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Thus, DMBT1 shapes salivary microbiota composition and protects against OSCC development. Dynamic, genotype-specific microbial shifts during carcinogenesis underscore the complex interplay between the oral microbiota and cancer progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s40168-026-02337-5","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:15:01Z","timestamp":1775816101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Loss of salivary agglutinin induces changes in the salivary microbiome and accelerates development of oral cancer"],"prefix":"10.1186","volume":"14","author":[{"given":"Marcell Costa","family":"de Medeiros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Danella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Hillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Furgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deneen M.","family":"Wellik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Inohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha J.","family":"D\u2019Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"19","key":"2337_CR1","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1128\/JB.00542-10","volume":"192","author":"FE Dewhirst","year":"2010","unstructured":"Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, et al. The human oral microbiome. J Bacteriol. 2010;192(19):5002\u201317. https:\/\/doi.org\/10.1128\/JB.00542-10.","journal-title":"J Bacteriol"},{"key":"2337_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174116","author":"KM Burcher","year":"2022","unstructured":"Burcher KM, Burcher JT, Inscore L, Bloomer CH, Furdui CM, Porosnicu M. A review of the role of oral microbiome in the development, detection, and management of head and neck squamous cell cancers. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14174116.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"2337_CR3","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/s41388-021-02137-1","volume":"41","author":"DN Frank","year":"2022","unstructured":"Frank DN, Qiu Y, Cao Y, Zhang S, Lu L, Kofonow JM, et al. A dysbiotic microbiome promotes head and neck squamous cell carcinoma. Oncogene. 2022;41(9):1269\u201380. https:\/\/doi.org\/10.1038\/s41388-021-02137-1.","journal-title":"Oncogene"},{"issue":"67","key":"2337_CR4","doi-asserted-by":"publisher","first-page":"110931","DOI":"10.18632\/oncotarget.20677","volume":"8","author":"R Guerrero-Preston","year":"2017","unstructured":"Guerrero-Preston R, White JR, Godoy-Vitorino F, Rodriguez-Hilario A, Navarro K, Gonzalez H, et al. High-resolution microbiome profiling uncovers Fusobacterium nucleatum, Lactobacillus gasseri\/johnsonii, and Lactobacillus vaginalis associated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation. Oncotarget. 2017;8(67):110931\u201348. https:\/\/doi.org\/10.18632\/oncotarget.20677.","journal-title":"Oncotarget"},{"key":"2337_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00267","volume":"8","author":"Y Lim","year":"2018","unstructured":"Lim Y, Fukuma N, Totsika M, Kenny L, Morrison M, Punyadeera C. The performance of an oral microbiome biomarker panel in predicting oral cavity and oropharyngeal cancers. Front Cell Infect Microbiol. 2018;8:267. https:\/\/doi.org\/10.3389\/fcimb.2018.00267.","journal-title":"Front Cell Infect Microbiol"},{"key":"2337_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.795777","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Li Z, Qi Y, Wen X, Zhang L. Metagenomic analysis reveals a changing microbiome associated with the depth of invasion of oral squamous cell carcinoma. Front Microbiol. 2022;13:795777. https:\/\/doi.org\/10.3389\/fmicb.2022.795777.","journal-title":"Front Microbiol"},{"issue":"1","key":"2337_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-3-27","volume":"3","author":"DL Mager","year":"2005","unstructured":"Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med. 2005;3(1):27. https:\/\/doi.org\/10.1186\/1479-5876-3-27.","journal-title":"J Transl Med"},{"key":"2337_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00323-19","author":"P Stashenko","year":"2019","unstructured":"Stashenko P, Yost S, Choi Y, Danciu T, Chen T, Yoganathan S, et al. The oral mouse microbiome promotes tumorigenesis in oral squamous cell carcinoma. mSystems. 2019. https:\/\/doi.org\/10.1128\/mSystems.00323-19.","journal-title":"mSystems"},{"key":"2337_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.oraloncology.2018.12.003","volume":"89","author":"CM Healy","year":"2019","unstructured":"Healy CM, Moran GP. The microbiome and oral cancer: more questions than answers. Oral Oncol. 2019;89:30\u20133. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.12.003.","journal-title":"Oral Oncol"},{"key":"2337_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00862","volume":"9","author":"CY Yang","year":"2018","unstructured":"Yang CY, Yeh YM, Yu HY, Chin CY, Hsu CW, Liu H, et al. Oral Microbiota Community Dynamics Associated With Oral Squamous Cell Carcinoma Staging. Front Microbiol. 2018;9:862. https:\/\/doi.org\/10.3389\/fmicb.2018.00862.","journal-title":"Front Microbiol"},{"key":"2337_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00476","volume":"9","author":"L Zhang","year":"2019","unstructured":"Zhang L, Liu Y, Zheng HJ, Zhang CP. The oral microbiota may have influence on oral cancer. Front Cell Infect Microbiol. 2019;9:476. https:\/\/doi.org\/10.3389\/fcimb.2019.00476.","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"2337_CR12","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/hed.27422","volume":"45","author":"HSL Ting","year":"2023","unstructured":"Ting HSL, Chen Z, Chan JYK. Systematic review on oral microbial dysbiosis and its clinical associations with head and neck squamous cell carcinoma. Head Neck. 2023;45(8):2120\u201335. https:\/\/doi.org\/10.1002\/hed.27422.","journal-title":"Head Neck"},{"issue":"1","key":"2337_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01677-w","volume":"11","author":"MC Medeiros","year":"2023","unstructured":"Medeiros MC, The S, Bellile E, Russo N, Schmitd L, Danella E, et al. Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancer. Microbiome. 2023;11(1):268. https:\/\/doi.org\/10.1186\/s40168-023-01677-w.","journal-title":"Microbiome"},{"issue":"11","key":"2337_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08953-x","volume":"32","author":"A de Freitas Neiva Lessa","year":"2024","unstructured":"de Freitas Neiva Lessa A, da Silva Amancio AMT, de Oliveira ACR, de Sousa SF, Caldeira PC, De Aguiar MCF, et al. Assessing the oral microbiome of head and neck cancer patients before and during radiotherapy. Support Care Cancer. 2024;32(11):752. https:\/\/doi.org\/10.1007\/s00520-024-08953-x.","journal-title":"Support Care Cancer"},{"key":"2337_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/bs.acr.2019.03.005","volume":"143","author":"C Buchta Rosean","year":"2019","unstructured":"Buchta Rosean C, Feng TY, Azar FN, Rutkowski MR. Impact of the microbiome on cancer progression and response to anti-cancer therapies. Adv Cancer Res. 2019;143:255\u201394. https:\/\/doi.org\/10.1016\/bs.acr.2019.03.005.","journal-title":"Adv Cancer Res"},{"key":"2337_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cellimm.2018.08.008","volume":"333","author":"BW Cross","year":"2018","unstructured":"Cross BW, Ruhl S. Glycan recognition at the saliva - oral microbiome interface. Cell Immunol. 2018;333:19\u201333. https:\/\/doi.org\/10.1016\/j.cellimm.2018.08.008.","journal-title":"Cell Immunol"},{"issue":"6","key":"2337_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1369\/0022155420927109","volume":"68","author":"A Bathum Nexoe","year":"2020","unstructured":"Bathum Nexoe A, Pedersen AA, von Huth S, Detlefsen S, Hansen PL, Holmskov U. Immunohistochemical localization of Deleted in Malignant Brain Tumors 1 in Normal Human Tissues. J Histochem Cytochem. 2020;68(6):377\u201387. https:\/\/doi.org\/10.1369\/0022155420927109.","journal-title":"J Histochem Cytochem"},{"issue":"6","key":"2337_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00251-017-0982-x","volume":"69","author":"FJ Bikker","year":"2017","unstructured":"Bikker FJ, End C, Ligtenberg AJM, Blaich S, Lyer S, Renner M, et al. The scavenging capacity of DMBT1 is impaired by germline deletions. Immunogenetics. 2017;69(6):401\u20137. https:\/\/doi.org\/10.1007\/s00251-017-0982-x.","journal-title":"Immunogenetics"},{"issue":"1","key":"2337_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49543-w","volume":"9","author":"J Li","year":"2019","unstructured":"Li J, Wan SJ, Metruccio MME, Ma S, Nazmi K, Bikker FJ, et al. DMBT1 inhibition of Pseudomonas aeruginosa twitching motility involves its N-glycosylation and cannot be conferred by the Scavenger Receptor Cysteine-Rich bacteria-binding peptide domain. Sci Rep. 2019;9(1):13146. https:\/\/doi.org\/10.1038\/s41598-019-49543-w.","journal-title":"Sci Rep"},{"issue":"1","key":"2337_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/0022034511399282","volume":"23","author":"D Malamud","year":"2011","unstructured":"Malamud D, Abrams WR, Barber CA, Weissman D, Rehtanz M, Golub E. Antiviral activities in human saliva. Adv Dent Res. 2011;23(1):34\u20137. https:\/\/doi.org\/10.1177\/0022034511399282.","journal-title":"Adv Dent Res"},{"issue":"7","key":"2337_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132942","volume":"10","author":"M Patyka","year":"2015","unstructured":"Patyka M, Malamud D, Weissman D, Abrams WR, Kurago Z. Periluminal distribution of HIV-binding target cells and Gp340 in the oral, cervical and sigmoid\/rectal mucosae: a mapping study. PLoS One. 2015;10(7):e0132942. https:\/\/doi.org\/10.1371\/journal.pone.0132942.","journal-title":"PLoS One"},{"key":"2337_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.molimm.2017.05.029","volume":"89","author":"MP Reichhardt","year":"2017","unstructured":"Reichhardt MP, Holmskov U, Meri S. SALSA-a dance on a slippery floor with changing partners. Mol Immunol. 2017;89:100\u201310. https:\/\/doi.org\/10.1016\/j.molimm.2017.05.029.","journal-title":"Mol Immunol"},{"key":"2337_CR23","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.chemosphere.2019.04.032","volume":"226","author":"S Zhang","year":"2019","unstructured":"Zhang S, Huo X, Zhang Y, Lu X, Xu C, Xu X. The association of PM2.5 with airway innate antimicrobial activities of salivary agglutinin and surfactant protein D. Chemosphere. 2019;226:915\u201323. https:\/\/doi.org\/10.1016\/j.chemosphere.2019.04.032.","journal-title":"Chemosphere"},{"key":"2337_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ebiom.2017.09.027","volume":"24","author":"A Esberg","year":"2017","unstructured":"Esberg A, Sheng N, Marell L, Claesson R, Persson K, Boren T, et al. Streptococcus mutans adhesin biotypes that match and predict individual caries development. EBioMedicine. 2017;24:205\u201315. https:\/\/doi.org\/10.1016\/j.ebiom.2017.09.027.","journal-title":"EBioMedicine"},{"key":"2337_CR25","doi-asserted-by":"crossref","unstructured":"Imai MA, Moriya T, Imai FL, Shiiba M, Bukawa H, Yokoe H, et al. Down-regulation of DMBT1 gene expression in human oral squamous cell carcinoma. Int J Mol Med. 2005;15(4):585\u20139 (PubMed PMID: 15754018).","DOI":"10.3892\/ijmm.15.4.585"},{"key":"2337_CR26","doi-asserted-by":"publisher","unstructured":"Singh P, Banerjee R, Piao S, Costa de Medeiros M, Bellile E, Liu M, Damodaran Puthiya Veettil D, Schmitd LB, Russo N, Danella E, Inglehart RC, Pineault KM, Wellik DM, Wolf G, D'Silva NJ. Squamous cell carcinoma subverts adjacent histologically normal epithelium to promote lateral invasion. J Exp Med. 2021;218(6). https:\/\/doi.org\/10.1084\/jem.20200944. PubMed PMID: 33835136; PMCID: PMC8042603.","DOI":"10.1084\/jem.20200944"},{"issue":"3","key":"2337_CR27","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/eji.200838689","volume":"39","author":"C End","year":"2009","unstructured":"End C, Bikker F, Renner M, Bergmann G, Lyer S, Blaich S, et al. DMBT1 functions as pattern-recognition molecule for poly-sulfated and poly-phosphorylated ligands. Eur J Immunol. 2009;39(3):833\u201342. https:\/\/doi.org\/10.1002\/eji.200838689.","journal-title":"Eur J Immunol"},{"issue":"1","key":"2337_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2249.2007.03528.x","volume":"151","author":"H Muller","year":"2008","unstructured":"Muller H, End C, Weiss C, Renner M, Bhandiwad A, Helmke BM, et al. Respiratory deleted in malignant brain tumours 1 (DMBT1) levels increase during lung maturation and infection. Clin Exp Immunol. 2008;151(1):123\u20139. https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03528.x.","journal-title":"Clin Exp Immunol"},{"key":"2337_CR29","unstructured":"Mollenhauer J, Herbertz S, Holmskov U, Tolnay M, Krebs I, Merlo A, et al. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res. 2000;60(6):1704\u201310 (PubMed PMID: 10749143)."},{"issue":"6371","key":"2337_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359(6371):97\u2013103. https:\/\/doi.org\/10.1126\/science.aan4236.","journal-title":"Science"},{"issue":"2","key":"2337_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10555-022-10028-4","volume":"41","author":"H Nagao-Kitamoto","year":"2022","unstructured":"Nagao-Kitamoto H, Kitamoto S, Kamada N. Inflammatory bowel disease and carcinogenesis. Cancer Metastasis Rev. 2022;41(2):301\u201316. https:\/\/doi.org\/10.1007\/s10555-022-10028-4.","journal-title":"Cancer Metastasis Rev"},{"issue":"6371","key":"2337_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillere R, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91\u20137. https:\/\/doi.org\/10.1126\/science.aan3706.","journal-title":"Science"},{"issue":"11","key":"2337_CR33","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1016\/j.celrep.2019.05.042","volume":"27","author":"R Caruso","year":"2019","unstructured":"Caruso R, Ono M, Bunker ME, Nunez G, Inohara N. Dynamic and asymmetric changes of the microbial communities after cohousing in laboratory mice. Cell Rep. 2019;27(11):3401-12 e3. https:\/\/doi.org\/10.1016\/j.celrep.2019.05.042.","journal-title":"Cell Rep"},{"issue":"8","key":"2337_CR34","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1084\/jem.20120504","volume":"209","author":"C Ubeda","year":"2012","unstructured":"Ubeda C, Lipuma L, Gobourne A, Viale A, Leiner I, Equinda M, et al. Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J Exp Med. 2012;209(8):1445\u201356. https:\/\/doi.org\/10.1084\/jem.20120504.","journal-title":"J Exp Med"},{"issue":"1","key":"2337_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13471-0","volume":"10","author":"Z Wang","year":"2019","unstructured":"Wang Z, Wu VH, Allevato MM, Gilardi M, He Y, Luis Callejas-Valera J, et al. Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4. Nat Commun. 2019;10(1):5546. https:\/\/doi.org\/10.1038\/s41467-019-13471-0.","journal-title":"Nat Commun"},{"issue":"6","key":"2337_CR36","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/hed.27022","volume":"44","author":"A Elseragy","year":"2022","unstructured":"Elseragy A, Bello IO, Wahab A, Coletta RD, Makitie AA, Leivo I, et al. Emerging histopathologic markers in early-stage oral tongue cancer: a systematic review and meta-analysis. Head Neck. 2022;44(6):1481\u201391. https:\/\/doi.org\/10.1002\/hed.27022.","journal-title":"Head Neck"},{"issue":"5","key":"2337_CR37","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/PAS.0b013e3181d95c37","volume":"34","author":"M Brandwein-Gensler","year":"2010","unstructured":"Brandwein-Gensler M, Smith RV, Wang B, Penner C, Theilken A, Broughel D, et al. Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma. Am J Surg Pathol. 2010;34(5):676\u201388. https:\/\/doi.org\/10.1097\/PAS.0b013e3181d95c37.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2337_CR38","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/hed.2880160506","volume":"16","author":"BL Hawkins","year":"1994","unstructured":"Hawkins BL, Heniford BW, Ackermann DM, Leonberger M, Martinez SA, Hendler FJ. 4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma. Head Neck. 1994;16(5):424\u201332. https:\/\/doi.org\/10.1002\/hed.2880160506.","journal-title":"Head Neck"},{"issue":"1 Pt 1","key":"2337_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1158\/1078-0432.ccr-0999-3","volume":"10","author":"XH Tang","year":"2004","unstructured":"Tang XH, Knudsen B, Bemis D, Tickoo S, Gudas LJ. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res. 2004;10(1 Pt 1):301\u201313. https:\/\/doi.org\/10.1158\/1078-0432.ccr-0999-3.","journal-title":"Clin Cancer Res"},{"key":"2337_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/bs.mcb.2021.01.001","volume":"163","author":"SH Sagheer","year":"2021","unstructured":"Sagheer SH, Whitaker-Menezes D, Han JYS, Curry JM, Martinez-Outschoorn U, Philp NJ. 4NQO induced carcinogenesis: a mouse model for oral squamous cell carcinoma. Methods Cell Biol. 2021;163:93\u2013111. https:\/\/doi.org\/10.1016\/bs.mcb.2021.01.001.","journal-title":"Methods Cell Biol"},{"issue":"13","key":"2337_CR41","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1158\/1078-0432.CCR-22-3496","volume":"29","author":"C Perez-Pacheco","year":"2023","unstructured":"Perez-Pacheco C, Schmitd LB, Furgal A, Bellile EL, Liu M, Fattah A, et al. Increased nerve density adversely affects outcome in oral cancer. Clin Cancer Res. 2023;29(13):2501\u201312. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-3496.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2337_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01055-4","volume":"9","author":"JM Baker","year":"2021","unstructured":"Baker JM, Hinkle KJ, McDonald RA, Brown CA, Falkowski NR, Huffnagle GB, et al. Whole lung tissue is the preferred sampling method for amplicon-based characterization of murine lung microbiota. Microbiome. 2021;9(1):99. https:\/\/doi.org\/10.1186\/s40168-021-01055-4.","journal-title":"Microbiome"},{"issue":"1(Suppl 1)","key":"2337_CR43","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1073\/pnas.1000080107","volume":"108","author":"JG Caporaso","year":"2011","unstructured":"Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A. 2011;108(1(Suppl 1)):4516\u201322. https:\/\/doi.org\/10.1073\/pnas.1000080107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"2337_CR44","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1128\/AEM.01043-13","volume":"79","author":"JJ Kozich","year":"2013","unstructured":"Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol. 2013;79(17):5112\u201320. https:\/\/doi.org\/10.1128\/AEM.01043-13.","journal-title":"Appl Environ Microbiol"},{"issue":"12","key":"2337_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008230","volume":"4","author":"PD Schloss","year":"2009","unstructured":"Schloss PD. A high-throughput DNA sequence aligner for microbial ecology studies. PLoS One. 2009;4(12):e8230. https:\/\/doi.org\/10.1371\/journal.pone.0008230.","journal-title":"PLoS One"},{"issue":"4","key":"2337_CR46","doi-asserted-by":"publisher","DOI":"10.1128\/mra.01063-23","volume":"13","author":"Q Wang","year":"2024","unstructured":"Wang Q, Cole JR. Updated RDP taxonomy and RDP classifier for more accurate taxonomic classification. Microbiol Resour Announc. 2024;13(4):e0106323. https:\/\/doi.org\/10.1128\/mra.01063-23.","journal-title":"Microbiol Resour Announc"},{"key":"2337_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00516","volume":"10","author":"G Yoon","year":"2019","unstructured":"Yoon G, Gaynanova I, Muller CL. Microbial networks in SPRING - semi-parametric rank-based correlation and partial correlation estimation for quantitative microbiome data. Front Genet. 2019;10:516. https:\/\/doi.org\/10.3389\/fgene.2019.00516.","journal-title":"Front Genet"},{"key":"2337_CR48","unstructured":"Liu H, Roeder K, Wasserman L. Stability Approach to Regularization Selection (StARS) for high dimensional graphical models. Adv Neural Inf Process Syst. 2010;24(2):1432\u201340. PubMed PMID: 25152607; PMCID: PMC4138724."},{"issue":"2","key":"2337_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.2517-6161.1982.tb01195.x","volume":"44","author":"J Aitchison","year":"1982","unstructured":"Aitchison J. The statistical analysis of compositional data. J Roy Stat Soc: Ser B (Methodol). 1982;44(2):21. https:\/\/doi.org\/10.1111\/j.2517-6161.1982.tb01195.x.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"1","key":"2337_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1541-0420.2012.01808.x","volume":"69","author":"J Goldsmith","year":"2013","unstructured":"Goldsmith J, Greven S, Crainiceanu C. Corrected confidence bands for functional data using principal components. Biometrics. 2013;69(1):41\u201351. https:\/\/doi.org\/10.1111\/j.1541-0420.2012.01808.x.","journal-title":"Biometrics"},{"key":"2337_CR51","doi-asserted-by":"crossref","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322. PubMed PMID: 20808728; PMCID: PMC2929880.","DOI":"10.18637\/jss.v033.i01"},{"key":"2337_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.591088","volume":"11","author":"M Irfan","year":"2020","unstructured":"Irfan M, Delgado RZR, Frias-Lopez J. The oral microbiome and cancer. Front Immunol. 2020;11:591088. https:\/\/doi.org\/10.3389\/fimmu.2020.591088.","journal-title":"Front Immunol"},{"key":"2337_CR53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.oraloncology.2017.08.009","volume":"73","author":"DR Farquhar","year":"2017","unstructured":"Farquhar DR, Divaris K, Mazul AL, Weissler MC, Zevallos JP, Olshan AF. Poor oral health affects survival in head and neck cancer. Oral Oncol. 2017;73:111\u20137. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.08.009.","journal-title":"Oral Oncol"},{"issue":"9","key":"2337_CR54","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1158\/1055-9965.EPI-09-0334","volume":"18","author":"M Tezal","year":"2009","unstructured":"Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, et al. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2009;18(9):2406\u201312. https:\/\/doi.org\/10.1158\/1055-9965.EPI-09-0334.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"2337_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066476","volume":"8","author":"HL Gong","year":"2013","unstructured":"Gong HL, Shi Y, Zhou L, Wu CP, Cao PY, Tao L, et al. The composition of microbiome in larynx and the throat biodiversity between laryngeal squamous cell carcinoma patients and control population. PLoS One. 2013;8(6):e66476. https:\/\/doi.org\/10.1371\/journal.pone.0066476.","journal-title":"PLoS One"},{"issue":"5","key":"2337_CR56","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/path.5047","volume":"244","author":"B Goodman","year":"2018","unstructured":"Goodman B, Gardner H. The microbiome and cancer. J Pathol. 2018;244(5):667\u201376. https:\/\/doi.org\/10.1002\/path.5047.","journal-title":"J Pathol"},{"issue":"8","key":"2337_CR57","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nrmicro2832","volume":"10","author":"K Faust","year":"2012","unstructured":"Faust K, Raes J. Microbial interactions: from networks to models. Nat Rev Microbiol. 2012;10(8):538\u201350. https:\/\/doi.org\/10.1038\/nrmicro2832.","journal-title":"Nat Rev Microbiol"},{"issue":"7484","key":"2337_CR58","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559\u201363. https:\/\/doi.org\/10.1038\/nature12820.","journal-title":"Nature"},{"issue":"5","key":"2337_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-5-r50","volume":"12","author":"JG Caporaso","year":"2011","unstructured":"Caporaso JG, Lauber CL, Costello EK, Berg-Lyons D, Gonzalez A, Stombaugh J, et al. Moving pictures of the human microbiome. Genome Biol. 2011;12(5):R50. https:\/\/doi.org\/10.1186\/gb-2011-12-5-r50.","journal-title":"Genome Biol"},{"issue":"7415","key":"2337_CR60","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","volume":"489","author":"CA Lozupone","year":"2012","unstructured":"Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220\u201330. https:\/\/doi.org\/10.1038\/nature11550.","journal-title":"Nature"},{"issue":"12","key":"2337_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04396-y","volume":"12","author":"D Dai","year":"2021","unstructured":"Dai D, Yang Y, Yu J, Dang T, Qin W, Teng L, et al. Interactions between gastric microbiota and metabolites in gastric cancer. Cell Death Dis. 2021;12(12):1104. https:\/\/doi.org\/10.1038\/s41419-021-04396-y.","journal-title":"Cell Death Dis"},{"key":"2337_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.827953","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Huang Y, Ding X, Yang Z, He L, Ning M, et al. A multi-omics study of familial lung cancer: microbiome and host gene expression patterns. Front Immunol. 2022;13:827953. https:\/\/doi.org\/10.3389\/fimmu.2022.827953.","journal-title":"Front Immunol"},{"key":"2337_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00520","volume":"8","author":"J Yang","year":"2018","unstructured":"Yang J, Mu X, Wang Y, Zhu D, Zhang J, Liang C, et al. Dysbiosis of the salivary microbiome is associated with non-smoking female lung cancer and correlated with immunocytochemistry markers. Front Oncol. 2018;8:520. https:\/\/doi.org\/10.3389\/fonc.2018.00520.","journal-title":"Front Oncol"},{"issue":"1","key":"2337_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80859-0","volume":"11","author":"D Gopinath","year":"2021","unstructured":"Gopinath D, Menon RK, Wie CC, Banerjee M, Panda S, Mandal D, et al. Differences in the bacteriome of swab, saliva, and tissue biopsies in oral cancer. Sci Rep. 2021;11(1):1181. https:\/\/doi.org\/10.1038\/s41598-020-80859-0.","journal-title":"Sci Rep"},{"key":"2337_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105657","volume":"124","author":"Y Dou","year":"2022","unstructured":"Dou Y, Ma C, Wang K, Liu S, Sun J, Tan W, et al. Dysbiotic tumor microbiota associates with head and neck squamous cell carcinoma outcomes. Oral Oncol. 2022;124:105657. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105657.","journal-title":"Oral Oncol"},{"issue":"12","key":"2337_CR66","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/1759-7714.15280","volume":"15","author":"K Feng","year":"2024","unstructured":"Feng K, Ren F, Shang Q, Wang X, Wang X. Association between oral microbiome and breast cancer in the east Asian population: a Mendelian randomization and case-control study. Thorac Cancer. 2024;15(12):974\u201386. https:\/\/doi.org\/10.1111\/1759-7714.15280.","journal-title":"Thorac Cancer"},{"key":"2337_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043466","author":"A Herreros-Pomares","year":"2023","unstructured":"Herreros-Pomares A, Hervas D, Bagan-Debon L, Jantus-Lewintre E, Gimeno-Cardona C, Bagan J. On the oral microbiome of oral potentially malignant and malignant disorders: dysbiosis, loss of diversity, and pathogens enrichment. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24043466.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2337_CR68","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ccell.2018.03.015","volume":"33","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell. 2018;33(4):570\u201380. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.015.","journal-title":"Cancer Cell"},{"issue":"1","key":"2337_CR69","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059.","journal-title":"Cancer Discov"},{"key":"2337_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4552","author":"GD Sepich-Poore","year":"2021","unstructured":"Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The microbiome and human cancer. Science. 2021. https:\/\/doi.org\/10.1126\/science.abc4552.","journal-title":"Science"},{"issue":"13","key":"2337_CR71","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1177\/0022034520945242","volume":"99","author":"FRF Teles","year":"2020","unstructured":"Teles FRF, Alawi F, Castilho RM, Wang Y. Association or causation? Exploring the oral microbiome and cancer links. J Dent Res. 2020;99(13):1411\u201324. https:\/\/doi.org\/10.1177\/0022034520945242.","journal-title":"J Dent Res"},{"issue":"2","key":"2337_CR72","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1432-1033.1983.tb07456.x","volume":"133","author":"T Ericson","year":"1983","unstructured":"Ericson T, Rundegren J. Characterization of a salivary agglutinin reacting with a serotype c strain of Streptococcus mutans. Eur J Biochem. 1983;133(2):255\u201361. https:\/\/doi.org\/10.1111\/j.1432-1033.1983.tb07456.x.","journal-title":"Eur J Biochem"},{"issue":"21","key":"2337_CR73","doi-asserted-by":"publisher","first-page":"13743","DOI":"10.1074\/jbc.272.21.13743","volume":"272","author":"U Holmskov","year":"1997","unstructured":"Holmskov U, Lawson P, Teisner B, Tornoe I, Willis AC, Morgan C, et al. Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule. J Biol Chem. 1997;272(21):13743\u20139. https:\/\/doi.org\/10.1074\/jbc.272.21.13743.","journal-title":"J Biol Chem"},{"issue":"1","key":"2337_CR74","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/ng0997-32","volume":"17","author":"J Mollenhauer","year":"1997","unstructured":"Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet. 1997;17(1):32\u20139. https:\/\/doi.org\/10.1038\/ng0997-32.","journal-title":"Nat Genet"},{"issue":"19","key":"2337_CR75","doi-asserted-by":"publisher","first-page":"10794","DOI":"10.1073\/pnas.96.19.10794","volume":"96","author":"U Holmskov","year":"1999","unstructured":"Holmskov U, Mollenhauer J, Madsen J, Vitved L, Gronlund J, Tornoe I, et al. Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci U S A. 1999;96(19):10794\u20139. https:\/\/doi.org\/10.1073\/pnas.96.19.10794.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"46","key":"2337_CR76","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1038\/sj.onc.1203071","volume":"18","author":"J Mollenhauer","year":"1999","unstructured":"Mollenhauer J, Holmskov U, Wiemann S, Krebs I, Herbertz S, Madsen J, et al. The genomic structure of the DMBT1 gene: evidence for a region with susceptibility to genomic instability. Oncogene. 1999;18(46):6233\u201340. https:\/\/doi.org\/10.1038\/sj.onc.1203071.","journal-title":"Oncogene"},{"issue":"46","key":"2337_CR77","doi-asserted-by":"publisher","first-page":"47699","DOI":"10.1074\/jbc.M406095200","volume":"279","author":"FJ Bikker","year":"2004","unstructured":"Bikker FJ, Ligtenberg AJ, End C, Renner M, Blaich S, Lyer S, et al. Bacteria binding by DMBT1\/SAG\/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains. J Biol Chem. 2004;279(46):47699\u2013703. https:\/\/doi.org\/10.1074\/jbc.M406095200.","journal-title":"J Biol Chem"},{"issue":"35","key":"2337_CR78","doi-asserted-by":"publisher","first-page":"32109","DOI":"10.1074\/jbc.M203788200","volume":"277","author":"FJ Bikker","year":"2002","unstructured":"Bikker FJ, Ligtenberg AJ, Nazmi K, Veerman EC, van\u2019t Hof W, Bolscher JG, et al. Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340\/DMBT1), a member of the scavenger receptor cysteine-rich superfamily. J Biol Chem. 2002;277(35):32109\u201315. https:\/\/doi.org\/10.1074\/jbc.M203788200.","journal-title":"J Biol Chem"},{"issue":"9","key":"2337_CR79","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1515\/BC.2008.135","volume":"389","author":"JT Leito","year":"2008","unstructured":"Leito JT, Ligtenberg AJ, Nazmi K, de Blieck-Hogervorst JM, Veerman EC, Nieuw Amerongen AV. A common binding motif for various bacteria of the bacteria-binding peptide SRCRP2 of DMBT1\/gp-340\/salivary agglutinin. Biol Chem. 2008;389(9):1193\u2013200. https:\/\/doi.org\/10.1515\/BC.2008.135.","journal-title":"Biol Chem"},{"issue":"5","key":"2337_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006392","volume":"13","author":"J Li","year":"2017","unstructured":"Li J, Metruccio MME, Evans DJ, Fleiszig SMJ. Mucosal fluid glycoprotein DMBT1 suppresses twitching motility and virulence of the opportunistic pathogen Pseudomonas aeruginosa. PLoS Pathog. 2017;13(5):e1006392. https:\/\/doi.org\/10.1371\/journal.ppat.1006392.","journal-title":"PLoS Pathog"},{"issue":"15","key":"2337_CR81","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41388-023-02649-y","volume":"42","author":"EB Danella","year":"2023","unstructured":"Danella EB, de Costa Meiros M, D\u2019Silva NJ. Cytokines secreted by inflamed oral mucosa: implications for oral cancer progression. Oncogene. 2023;42(15):1159\u201365. https:\/\/doi.org\/10.1038\/s41388-023-02649-y.","journal-title":"Oncogene"},{"issue":"4","key":"2337_CR82","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/omi.12096","volume":"30","author":"N Bostanci","year":"2015","unstructured":"Bostanci N, Bao K, Wahlander A, Grossmann J, Thurnheer T, Belibasakis GN. Secretome of gingival epithelium in response to subgingival biofilms. Mol Oral Microbiol. 2015;30(4):323\u201335. https:\/\/doi.org\/10.1111\/omi.12096.","journal-title":"Mol Oral Microbiol"},{"issue":"1","key":"2337_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52115-7","volume":"9","author":"JL Brown","year":"2019","unstructured":"Brown JL, Johnston W, Delaney C, Rajendran R, Butcher J, Khan S, et al. Biofilm-stimulated epithelium modulates the inflammatory responses in co-cultured immune cells. Sci Rep. 2019;9(1):15779. https:\/\/doi.org\/10.1038\/s41598-019-52115-7.","journal-title":"Sci Rep"},{"key":"2337_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/omi.12251","author":"JL Ebersole","year":"2019","unstructured":"Ebersole JL, Peyyala R, Gonzalez OA. Biofilm-induced profiles of immune response gene expression by oral epithelial cells. Mol Oral Microbiol. 2019. https:\/\/doi.org\/10.1111\/omi.12251.","journal-title":"Mol Oral Microbiol"},{"issue":"3","key":"2337_CR85","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/jre.12395","volume":"52","author":"G Ramage","year":"2017","unstructured":"Ramage G, Lappin DF, Millhouse E, Malcolm J, Jose A, Yang J, et al. The epithelial cell response to health and disease associated oral biofilm models. J Periodontal Res. 2017;52(3):325\u201333. https:\/\/doi.org\/10.1111\/jre.12395.","journal-title":"J Periodontal Res"},{"issue":"1","key":"2337_CR86","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1600-051X.2009.01505.x","volume":"37","author":"PG Stathopoulou","year":"2010","unstructured":"Stathopoulou PG, Benakanakere MR, Galicia JC, Kinane DF. Epithelial cell pro-inflammatory cytokine response differs across dental plaque bacterial species. J Clin Periodontol. 2010;37(1):24\u20139. https:\/\/doi.org\/10.1111\/j.1600-051X.2009.01505.x.","journal-title":"J Clin Periodontol"}],"container-title":["Microbiome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40168-026-02337-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-026-02337-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-026-02337-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:31:23Z","timestamp":1779233483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40168-026-02337-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2337"],"URL":"https:\/\/doi.org\/10.1186\/s40168-026-02337-5","relation":{},"ISSN":["2049-2618"],"issn-type":[{"value":"2049-2618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prior to initiation, all animal studies were approved by the University of Michigan Institutional Animal Care and Use Committee (IACUC, PRO00010723).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Does not apply (no individual person\u2019s data used).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NJD has\u00a0received material support (i.e. reagent) from Eterna Therapeutics, not discussed in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}